← Back to all clusters

Cluster 123

10 diseases · 19 shared-gene connections
10 Diseases
56 Unique genes
0.172 Avg. similarity score
Benign congenital myopathy Most-connected disease (6 links)
Log in to save this analysis

Save This Analysis

Disease Searched: progressive muscular dystrophy Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
DMD 7 / 10 Becker muscular dystrophy, Benign congenital myopathy, Clinodactyly, Duchenne muscular dystrophy and 3 more
FH 2 / 10 hereditary leiomyomatosis and renal cell cancer, Leiomyosarcoma
RBM8A 2 / 10 Clinodactyly, thrombocytopenia-absent radius syndrome
USP18 2 / 10 Leiomyosarcoma, Pseudo-torch syndrome
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Dilated cardiomyopathy KEGG 5 / 105 10.2× 1.24e-4 2.70e-3 ✓ sig.
Regulation of IFNA signaling Reactome 3 / 24 26.8× 1.81e-4 3.66e-3 ✓ sig.
Arrhythmogenic right ventricular cardiomyopathy KEGG 4 / 86 10.0× 6.78e-4 1.03e-2 ✓ sig.
WNT mediated activation of DVL Reactome 2 / 9 47.7× 7.53e-4 1.12e-2 ✓ sig.
Adenylate cyclase activating pathway Reactome 2 / 10 42.9× 9.38e-4 1.33e-2 ✓ sig.
Ovarian steroidogenesis KEGG 3 / 52 12.4× 1.81e-3 2.16e-2 ✓ sig.
Adenylate cyclase inhibitory pathway Reactome 2 / 14 30.6× 1.87e-3 2.22e-2 ✓ sig.
Hedgehog 'off' state Reactome 3 / 56 11.5× 2.23e-3 2.53e-2 ✓ sig.
Regulation of lipolysis in adipocytes KEGG 3 / 59 10.9× 2.59e-3 2.83e-2 ✓ sig.
PKA activation in glucagon signalling Reactome 2 / 17 25.2× 2.78e-3 2.97e-2 ✓ sig.
PKA activation Reactome 2 / 19 22.6× 3.47e-3 3.46e-2 ✓ sig.
Long-term potentiation KEGG 3 / 67 9.6× 3.72e-3 3.64e-2 ✓ sig.
SUMOylation of chromatin organization proteins Reactome 3 / 70 9.2× 4.21e-3 3.96e-2 ✓ sig.
PTEN Loss of Function in Cancer Reactome 1 / 1 214× 4.66e-3 4.24e-2 ✓ sig.
Biosynthesis of EPA-derived SPMs Reactome 1 / 1 214× 4.66e-3 4.24e-2 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
maintenance of blood-brain barrier GO:0035633 3 / 34 29.4× 1.43e-4 4.03e-3 ✓ sig.
regulation of heart rate GO:0002027 3 / 39 25.7× 2.16e-4 5.43e-3 ✓ sig.
positive regulation of CREB transcription factor activity GO:0032793 2 / 10 66.7× 3.91e-4 8.28e-3 ✓ sig.
cAMP biosynthetic process GO:0006171 2 / 11 60.7× 4.77e-4 9.48e-3 ✓ sig.
intracellular signal transduction GO:0035556 7 / 471 5.0× 4.93e-4 9.65e-3 ✓ sig.
regulation of cell differentiation GO:0045595 3 / 54 18.5× 5.67e-4 1.06e-2 ✓ sig.
neuroinflammatory response GO:0150076 2 / 12 55.6× 5.71e-4 1.07e-2 ✓ sig.
cell communication by electrical coupling involved in cardiac conduction GO:0086064 2 / 12 55.6× 5.71e-4 1.07e-2 ✓ sig.
positive regulation of receptor recycling GO:0001921 2 / 14 47.7× 7.84e-4 1.32e-2 ✓ sig.
cellular response to forskolin GO:1904322 2 / 16 41.7× 1.03e-3 1.57e-2 ✓ sig.
regulation of sodium ion transmembrane transport GO:1902305 2 / 16 41.7× 1.03e-3 1.57e-2 ✓ sig.
ventricular cardiac muscle cell action potential GO:0086005 2 / 17 39.3× 1.17e-3 1.70e-2 ✓ sig.
cyclic nucleotide biosynthetic process GO:0009190 2 / 18 37.1× 1.31e-3 1.81e-2 ✓ sig.
positive regulation of synaptic transmission GO:0050806 2 / 18 37.1× 1.31e-3 1.81e-2 ✓ sig.
cellular response to glucose stimulus GO:0071333 3 / 74 13.5× 1.42e-3 1.90e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Benign congenital myopathy Dystrophinopathy 0.500 1 6.49e-5 2.32e-4 ✓ sig.
Benign congenital myopathy progressive muscular dystrophy 0.500 1 6.49e-5 2.32e-4 ✓ sig.
Dystrophinopathy progressive muscular dystrophy 0.500 1 6.49e-5 2.32e-4 ✓ sig.
Becker muscular dystrophy Dystrophinopathy 0.250 1 1.95e-4 5.32e-4 ✓ sig.
Becker muscular dystrophy progressive muscular dystrophy 0.250 1 1.95e-4 5.32e-4 ✓ sig.
Becker muscular dystrophy Benign congenital myopathy 0.250 1 1.95e-4 5.32e-4 ✓ sig.
Benign congenital myopathy Leiomyosarcoma 0.125 1 4.55e-4 9.70e-4 ✓ sig.
Leiomyosarcoma progressive muscular dystrophy 0.125 1 4.55e-4 9.70e-4 ✓ sig.
hereditary leiomyomatosis and renal cell cancer Leiomyosarcoma 0.125 1 4.55e-4 9.70e-4 ✓ sig.
Dystrophinopathy Leiomyosarcoma 0.125 1 4.55e-4 9.70e-4 ✓ sig.
Clinodactyly thrombocytopenia-absent radius syndrome 0.053 1 1.17e-3 1.89e-3 ✓ sig.
Clinodactyly progressive muscular dystrophy 0.053 1 1.17e-3 1.89e-3 ✓ sig.
Clinodactyly Dystrophinopathy 0.053 1 1.17e-3 1.89e-3 ✓ sig.
Benign congenital myopathy Clinodactyly 0.053 1 1.17e-3 1.89e-3 ✓ sig.
Leiomyosarcoma Pseudo-torch syndrome 0.100 1 1.36e-3 2.15e-3 ✓ sig.
Becker muscular dystrophy Leiomyosarcoma 0.100 1 1.36e-3 2.15e-3 ✓ sig.
Duchenne muscular dystrophy progressive muscular dystrophy 0.033 1 1.88e-3 2.76e-3 ✓ sig.
Duchenne muscular dystrophy Dystrophinopathy 0.033 1 1.88e-3 2.76e-3 ✓ sig.
Benign congenital myopathy Duchenne muscular dystrophy 0.033 1 1.88e-3 2.76e-3 ✓ sig.